Skip to main content
HUALAN GROUP CO.,LTD. logo

HUALAN GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 301027 ISIN · CNE100004MH7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2025-04-20 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 301027

About HUALAN GROUP CO.,LTD.

https://www.gxhl.com

Hualan Group Co., Ltd. specializes in the research, development, and manufacturing of primary pharmaceutical packaging materials. The company's core product portfolio includes high-quality butyl rubber stoppers, aluminum-plastic combination caps, and plastic components designed for injectable medications and infusion sets. These products are engineered to ensure drug stability and compatibility, meeting international quality standards such as GMP. Serving a global clientele of pharmaceutical manufacturers, the group focuses on advanced material science and precision manufacturing to provide secure sealing solutions for vaccines, antibiotics, and blood products. By integrating R&D with large-scale production capabilities, the company maintains a significant role in the pharmaceutical supply chain, emphasizing safety and reliability in drug delivery systems.

Recent filings

Filing Released Lang Actions
2024年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as "华蓝集团股份公司2024 年年度报告摘要" which translates to "Hualan Group Co., Ltd. 2024 Annual Report Summary." It contains detailed financial data for the year 2024, including total assets, net profit, revenue, and quarterly financial data. It also discusses business operations, strategic cooperation, and shareholder information. The document is about 7,939 characters long, which is substantial and contains actual financial data and analysis, not just an announcement or a certification. The content aligns with the characteristics of an Annual Report (10-K) as it covers company activity, financial performance, and future outlook comprehensively for the fiscal year 2024. Therefore, the correct classification is Annual Report (10-K). FY 2024
2025-04-20 Chinese
关于续聘2025年度会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the reappointment of an accounting firm (auditor) for the fiscal year 2025. It details the qualifications, integrity, and audit fees of the accounting firm, as well as the approval process by the audit committee, board of directors, and supervisory board. It does not contain actual financial statements or audit results but is a formal notice about the auditor appointment process. The document length is 3236 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is an official announcement related to audit matters but not the audit report itself.
2025-04-20 Chinese
关于终止实施2022年限制性股票激励计划暨回购注销、作废限制性股票的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Huazhong Group regarding the termination of the 2022 restricted stock incentive plan, including details about the repurchase and cancellation of restricted stocks. It includes board and supervisory committee meeting resolutions, legal opinions, and detailed explanations about the stock repurchase price, quantity, and impact on share capital structure. The document is a formal disclosure of corporate actions related to stock incentives and repurchase, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive details and is over 5,000 characters. The content fits best under the category of Capital/Financing Update (CAP) because it deals with stock repurchase, cancellation, and changes in capital structure related to the incentive plan termination.
2025-04-20 Chinese
2024年度财务决算报告
Annual Report Classification · 95% confidence The document is titled as the "2024 年度财务决算报告" which translates to "2024 Annual Financial Settlement Report". It contains detailed financial statements including balance sheets, profit and loss statements, and cash flow statements for the full fiscal year 2024. The report is audited by an accounting firm with an unqualified opinion, indicating it is a full annual financial report. The length of the document (4449 characters) is just under 5000 but it contains substantive financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Annual Report (10-K). FY 2024
2025-04-20 Chinese
第五届董事会独立董事专门会议第一次会议决议
Board/Management Information Classification · 95% confidence The document is a resolution from the independent directors' special meeting of the board of directors of 华蓝集团股份公司. It details the meeting notice, attendance, legal compliance, and approval of specific agenda items related to daily related-party transactions and termination of a restricted stock incentive plan. The content focuses on board-level decisions and approvals rather than financial results, audit opinions, or shareholder voting results. It is not an annual report, audit report, earnings release, or voting results announcement. The document is clearly about board/management decisions and approvals, fitting the Board/Management Information (MANG) category. The document length is short and specific to board resolutions, confirming the classification.
2025-04-20 Chinese
关于2024年计提减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 华蓝集团股份公司 regarding the impairment provisions for the year 2024. It details the amounts of impairment provisions made, the accounting policies applied, and the impact on the company's profit. The document includes specific financial figures and explanations of the impairment testing methods. It is not a full annual or interim report but a specific announcement about impairment provisions. The document length is 3823 characters, which is relatively short but contains substantive financial data about impairment provisions. It is not a report publication announcement or a certification letter. The content fits best under a regulatory announcement about impairment provisions, which is typically classified as a Regulatory Filing (RNS) because it does not constitute a full financial report like an annual or interim report, nor is it a simple announcement of a report's publication. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-04-20 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.